Find Resources
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Summary Report/Recommendations
This commentary discusses the importance of inclusive health systems strengthening in promoting equity during health emergencies, using the example of disability inclusion in the COVID-19 pandemic. It highlights the increased risks faced by persons with disabilities during the pandemic and the barriers they encounter in accessing healthcare. It emphasizes the need for accessible and comprehensive health emergency preparedness and response plans that consider the needs of persons with disabilities. It also explores strategies for disability inclusion in COVID-19 responses, such as producing accessible public health information and involving organizations of persons with disabilities in decision-making processes. Opportunities to strengthen inclusion and equity in COVID-19 responses include equitable access to telehealth and inclusive decision-making processes.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Summary Report/Recommendations
The Johns Hopkins University COVID-19 dashboard, which was launched one day after the first confirmed US COVID-19 case, provides an accessible means of viewing COVID-19 cases, deaths, recoveries, and vaccination rates globally. This report covers the data collection process and challenges faced while doing so, especially those related to pulling data from various sources. It offers ways for public health agencies to adapt their approaches for reporting data.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This article seeks to assess COVID-19 case and mortality rates in non-Hispanic American Indian and Alaska Natives (AI/AN) through an analysis of laboratory-reported COVID-19 data from January 22-July 3, 2020, for 23 U.S. states. The results show that AI/AN individuals are 3.5 times more likely to contract COVID-19 than White individuals, and more accurate race/ethnicity data must be reported by all states to more accurately represent this population.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Summary Report/Recommendations
This article discusses the current trends for collecting race/ethnicity data and other social determinants of health, which evolved from the 1978 Office of Management and Budget directive “Race and Ethnic Standards for Federal Statistics and Administrative Reporting.” The article comments on the inability of the current system to capture the nuance necessary to depict and address health inequities within the United States, and advocates for the immediate adoption of collecting primary/preferred language and country of birth/origin to capture more complete data on individuals.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This article discusses incorporating geographic information science and technology (GIS&T) into COVID-19 pandemic surveillance, modeling, and response. Applications include: 1) developing spatial data infrastructures for surveillance and data-sharing; 2) incorporating mobility data in infectious disease forecasting; 3) using geospatial technologies for digital contact tracing; 4) integrating geographic data into COVID-19 modeling; 5) investigating geographic social vulnerabilities and disparities; and 6) communicating the status of the disease or status of facilities for return-to-normal operations.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Summary Report/Recommendations
This article discusses use of digital contract tracing applications in France during the COVID-19 pandemic. While these apps have been created to help mitigate spread of COVID-19 by offering health advice on isolation and testing, they are not being used by the majority of the population. In May 2020, the COVID-19 Control and Society Connection Council (CLL) was established to issue advice and guidance on the national epidemic digital systems. This paper illustrates the recommendations by this committee for the improvement of these applications.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Summary Report/Recommendations
This study uses data from the COVID Tracking Project’s Racial Data Tracker, which aggregates state-level COVID-19 reporting and tracking databases to determine racial/ethnic trends of COVID-19 incidence and evaluate the racial/ethnic distribution of COVID-19 related mortality in the US. Results found that disparities are more apparent at the county and city level, and discusses the importance of transparent, local data in order to allow for greater precision in resource allocation and effective policy changes aimed at reducing disparities. The study includes choropleth maps of the results by state.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study, Summary Report/Recommendations
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in in the development and deployment of vaccines against emerging viruses. Recommendations include bolstering health information surveillance systems, stakeholder engagement with health care, women, families and communities, and changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Summary Report/Recommendations
In this report, the National Vaccine Advisory Committee (NVAC) discusses maternal immunizations best practices, as well as gaps to implementation recommendations. One recommendation includes focusing efforts to improve financing for immunization services during pregnancy and the postpartum period. Public health and health care partners can support efforts promoting new payment and delivery models, patient-centered medical homes, and accountable care organizations. NVAC also recommends partnering with professional organizations and other maternal immunization stakeholders to develop toolkits and guidance for improving processes.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This report highlights the efficacy of COVID-19 mRNA vaccines (2-dose series) for pregnant mothers and their infants. In the aftermath of the Delta and Omicron waves, infants born to unvaccinated mothers were more likely to be among those hospitalized for COVID-19.